The Top DividendRank'ed Stocks With Insider Buying » Also see: IT Stock Predictions Institutional Holders of SPYX SWTX Options Chain The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, ...
The Dividend History page provides a single page to review all of the aggregated Dividend payment information.Historical information is not adjusted for stock splits.Visit ourDividend Calendar: Please note that the dividend history for Nasdaq stocks may also be combined the regular with the special ...
Dropdown Markets DJIA F 44,478 -102 -0.23% S&P F 6,068.75 -20.00 -0.33% NASDAQ F 21,721.75 -124.75 -0.57% Gold 2,921.20 -13.20 -0.45% Silver 31.900 -0.591 -1.82% Crude Oil 73.62 1.30 1.80% Latest News All Times Eastern scroll up scroll down 8:53a Barron's Tesla Stock Is ...
Ahead of its quarterly earnings report scheduled for July 25,Bristol-Myers Squibb(NYSE:BMY) found itself trading at fresh 52-week lows. While BMY stock has kept up with theiShares Nasdaq Biotechnology ETF(NASDAQ:IBB) in that time, investors are getting increasingly negative on the company. Wi...
Bristol-Myers Squibb CoBMY:NYSE RT Quote|Last NASDAQ LS, VOL From CTA|USD After Hours:Last |5:32 AM EST 56.09+0.26(+0.47%) Volume 1,774 Close 55.83+0.04(+0.07%) Volume 10,412,087 52 week range 39.35-61.10 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...
Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. ...
First Trust Nasdaq Pharmaceuticals ETF ZWHC:CA 30.59 -0.71% BMO Covered Call Health Care ETF RDIVInvesco S&P Ultra Dividend Revenue ETF 50.01 Post. 50.00 -0.64% -0.02% CAMX 30.94 -0.80% Cambiar Aggressive Value ETF PJPInvesco Pharmaceuticals ETF 85.60 Post. 85.60 -1.71% 0.00%Seeking...
Perhaps they’re too occupied with coronavirus stocks likeModerna(NASDAQ:MRNA) to see the underpriced asset that has been there all along. Perhaps the upcoming earnings release will open their eyes to this outstanding opportunity. Apparently, the expertsare predicting $1.43 per share in quarterly ea...
picks analysis by sector energy communication services real estate consumer staples tech basic materials healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq ...
October 7, 2010: Our approach to this summer’s range bound market proved far too defensive for the record setting advance in September. Early in the month we sold most of our fully priced momentum based securities in the Income Plus account. This included Sirona Denta...